Antagonistic Effects of Transforming Growth Factor-β on Vitamin D3 Enhancement of Osteocalcin and Osteopontin Transcription: Reduced Interactions of Vitamin D Receptor/Retinoid X Receptor Complexes with Vitamin D Response Elements

Endocrinology

Volumn 137, Issue 5, 1996, Pages 2001-2011

  Staal, A ^a,b   Van Wijnen, A J ^b   Desai, R K ^b   Pols, H A P ^a,b   Birkenhager J C ^a,b   Deluca, H F ^b,c   Denhardt, D T ^b,d   Stein, J L ^b   Van Leeuwen, J P T M ^a,b   Stein, G S ^b   Lian, J B ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; OSTEOCALCIN; OSTEOPONTIN; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; VITAMIN D RECEPTOR; VITAMIN RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONE RESPONSIVE ELEMENT; IMMUNOBLOTTING; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; RAT; RECEPTOR DOWN REGULATION; REPORTER GENE; TRANSCRIPTION REGULATION; VITAMIN D RESPONSIVE ELEMENT;

ANIMALS; BLOTTING, WESTERN; CALCITRIOL; DNA; GENE EXPRESSION REGULATION; MACROMOLECULAR SUBSTANCES; MICE; OSTEOCALCIN; OSTEOPONTIN; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; SIALOGLYCOPROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0029874137     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.5.8612541     Document Type: Article

References (67)

1. Boskey AL 1992 Mineral-matrix interactions in bone and cartilage. Clin Ortho Rel Res 281:244-274
2. Stein GS, Lian JB 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424-442
3. Lian JB, Tassinari M, Glowacki J 1984 Resorption of implanted bone prepared from normal and warfarin-treated rats. J Clin Invest 73:1223-1226
4. Chenu C, Colucci S, Grano M, Zigrino P, Barattolo R, Zambonin G, Baldini N, Vergnaud P, Delmas PD, Zallone AZ 1994 Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol 127:1149-1158
5. Glowacki J, Lian JB 1987 Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants. Cell Diff 21:247-254
6. Reinholt FP, Hultenby K, Oldberg A, Heinegard D 1990 Osteopontin - a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 87:4473-4475
7. Flores ME, Norgard M, Heinegard D, Reinholt FP, Andersson G 1992 RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin. Exp Cell Res 201:526-530
8. DeLuca HF 1988 The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J 2:224-236
9. Owen TA, Aronow MA, Barone LM, Bettencourt B, Stein G, Lian JB 1991 Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128:1496-1504
10. Tsai MJ, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid superfamily members. Annu Rev Biochem 63:451-486
11. 3. Proc Natl Acad Sci USA 86:4455-4459
12. Ozono K, Liao J, Keener SA, Scott RA, Pike JW 1990 The vitamin D-responsive element in the human osteocalcin gene. J Biol Chem 265:21881-21888
13. 3. Proc Natl Acad Sci USA 87:369-373
14. Markose ER, Stein JL, Stein GS, Lian JB 1990 Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc Natl Acad Sci USA 87:1701-1705
15. 3-mediated transcriptional activation. Mol Endocrinol 6:557-562
16. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87:9995-9999
17. 3 24-hydroxylase gene. J Biol Chem 269:10545-10550
18. 24 gene. Nucleic Acids Res 22:2410-2416
19. Zierold C, Darwish HM, DeLuca HF 1995 Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J Biol Chem 270:1675-1678
20. Kahlen JP, Carlberg C 1994 Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter. Biochem Biophys Res Commun 202:1366-1372
21. Gill RK, Christakos S 1993 Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3-and butyrate-inducible responses. Proc Natl Acad Sci USA 90:2984-2988
22. Cao X, Ross FP, Zhang L, MacDonald PN, Chappel J, Teitelbaum SL 1993 Cloning of the promoter for the avian integrin beta 3 subunit gene and its regulation by 1,25-dihydroxyvitamin D3. J Biol Chem 268:27371-27380
23. Robey PG, Young MF, Flanders KC, Roche NS, Kondaiah P, Reddi AH, Termine JD, Sporn MB, Roberts AB 1987 Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J Cell Biol 105:457-463
24. Bonewald LF, Dallas SL 1994 Role of active and latent transforming growth factor β in bone formation. J Cell Biochem 55:350-357
25. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B 1987 Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105:1039-1045
26. Massague J 1990 The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641
27. Oursler MJ 1994 Osteoclast synthesis and secretion and activation of latent transforming growth factor beta. J Bone Miner Res 9:443-452
28. Canalis E, Pash J, Varghese S 1993 Skeletal growth factors. Crit Rev Eukaryot Gene Expr 3:155-166
29. Rosen DM, Stempien SA, Thompson AY, Seyedin SM 1988 Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro. J Cell Physiol 134:337-346
30. Wrana JL, Maeno M, Hawrylyshyn B, Yao KI Domenicucci C, Sodek J 1988 Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations. J Cell Biol 106:915-924
31. Rodan GA, Noda M 1991 Gene expression in osteoblastic cells. Crit Rev Eukaryot Gene Exp 1:85-98
32. Katagiri R, Lee T, Takeshima H, Suda T, Tunaka H, Omura S 1990 Transforming growth factor-beta modulates proliferation and differentiation of mouse clonal osteoblastic MC3T3-E1 cells depending on their maturation stages. Bone Miner 11:285-293
33. Ber R, Kubota T, Sodek J, Aubin JE 1991 Effects of transforming growth factor-beta on normal clonal bone cell populations. Biochem Cell Biol 69:132-140
34. Breen EC, Ignotz RA, McCabe LM, Stein JL, Stein GS, Lian JB 1994 TGFβ alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. J Cell Physiol 160:323-335
35. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR 1994 Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855-863
36. 3 on differentiation of a human osteosarcoma (MG-63). J Biol Chem 267:8943-8949
37. 3 action in osteoblast-like cells. Bone Miner 26:27-42
38. 3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Differentiation 55:153-163
39. Gundberg CM, Hauschka PV, Lian JB, Gallop PM 1984 Osteocalcin: isolation, characterization, and detection. Methods Enzymol 107:516-544
40. Shakoori AR, van Wijnen AJ, Bortell R, Owen TA, Stein JL, Lian JB, Stein GS 1994 Variations in Vitamin D Receptor transcription factor complexes associated with the osteocalcin gene vitamin D responsive element in osteoblasts and osteosarcoma cells. J Cell Biochem 55:1-12
41. van Wijnen AJ, van den Ent FMI, Lian JB, Stein JL, Stein GS 1992 Overlapping and CpG methylation-sensitive protein-DNA interactions at the histone H4 transcriptional cell cycle domain: distinctions between two human H4 gene promoters. Mol Cell Biol 12:3273-3287
42. Aslam F, Shalhoub V, van Wijnen AJ, Banerjee C, Bortell R, Shakoori AR, Litwack G, Stein JL, Stein GS, Lian JB Contributions of distal, proximal promoter elements to glucocorticoid regulation of osteocalcin gene transcription. Mol Endocrinol 9:679-690
43. Ausubel FM, Brent R, Kingston R, Moore DD, Seidman JG, Smith JA, Struhl K (eds) 1989 in Current Protocols in Molecular Biology, Wiley Press, New York
44. Shalhoub V, Jackson ME, Lian JB, Stein GS, Marks Jr SC 1991 Gene expression during skeletal development in three osteopetrotic rat mutations: evidence for osteoblast abnormalities. J Biol Chem 266: 9847-9856
45. Pols HAP, Birkenhäger JC, Schilte JP, Visser TJ 1988 Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells. Biochim Biophys Acta 970:122-129
46. Kingsley DM 1994 The TGFβ superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev 8:133-146
47. Banerjee C, Stein JL, van Wijnen AJ, Frenkel B, Lian JB, Stein GS 1996 Transforming growth factor-β1 responsiveness of the rat osteocalcin gene is mediated by an activator protein-1 binding site. Endocrinology 137:1991-2000
48. Owen TA, Bortell R, Shalhoub V, Heinrichs A, Stein JL, Stein GS, Lian JB 1993 Postproliferative transcription of the rat osteocalcin gene is reflected by vitamin D-responsive developmental modifications in protein-DNA interactions at basal and enhancer promoter elements. Proc Natl Acad Sci USA 90:1503-1507
49. Bortell R, Owen TA, Bidwell JP, Gavazzo P, Breen E, van Wijnen AJ, DeLuca HF, Stein JL, Lian JB, Stein GS 1992 Vitamin D-responsive protein-DNA interactions at multiple promoter regulatory elements that contribute to the level of rat osteocalcin gene expression. Proc Natl Acad Sci USA 89:6119-6123
50. Desai RK, van Wijnen AJ, Stein JL, Stein GS, Lian JB, Control of 1,25-dihydroxyvitamin D3 receptor mediated enhancement of osteocalcin gene transcription: effects of perturbing phosphorylation pathwavs by okadaic acid and staurosporine. Endocrinology 136: 5685-5693
51. Pertovaara L, Sistonen L, Bos TJ, Vogt PK, Keski-Oja J, Alitalo K 1989 Enhanced jun gene expression is an early genomic response to transforming growth factor β stimulation. Mol Cell Biol 9:1255-1262
52. Candeliere GA, Prud'homme J, St.-Arnaud R 1991 Differential stimulation of tos and jun family members by calcitriol in osteoblastic cells. Mol Endocrinol 12:1780-1788
53. Owen TA, Bortell R, Yocum SA, Smock SL, Zhang M, Abate C, Shalhoub V, Aronin N, Wright KL, van Wijnen AJ, Stein JL, Curran T, Lian JB, Stein GS 1990 Coordinate occupancy of AP-1 sites in the vitamin D responsive and CCAAT box elements by fos-jun in the osteocalcin gene: a model for phenotype suppression of transcription. Proc Natl Acad Sci USA 87:9990-9994
54. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Näär AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG 1991 RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266
55. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM 1992 Retinoid × receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 355:446-449
56. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Gamier JM, Mader S, Chambon P 1992 Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377-395
57. Marks MS, Hallenbeck PL, Nagata T, Segars JH, Appella E, Nikodem VM, Ozato K 1992 H-2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J 11:1419-1435
58. Breen EC, van Wijnen AJ, Lian JB, Stein GS, Stein JL 1994 In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D-dependent transcriptional upregulation in intact cells. Proc Natl Acad Sci USA 91:12902-12906
59. Kuno H, Kurian SM, Hendy GN, White J, DeLuca HF, Evans CO, Nanes MS 1994 Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Endocrinology 134:2524-2531
60. Arbour NC, Prahl JM, DeLuca HF 1993 Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3. Mol Endocrinol 7:1307-1312
61. Hsieh JC, Jurutka PW, Nakajima S, Galligan MS, Haussler CA, Shimizu Y, Shimizu N, Whitfield GK, Haussier MR 1993 Phosphorylation of the human vitamin D receptor by protein kinase C. Biochemical and functional evaluation of the serine 51 recognition site. J Biol Chem 268:15118-15126
62. 3 receptor. Biochim Biophys Acta 1167:29-36
63. Ohtsuki M, Massague J 1992 Evidence for the involvement of protein kinase activity in Transforming Growth Factor-β signal transduction. Mol Celll Biol 12:261-265
64. van Leeuwen JPTM, Birkenhäger JC, van den Bemd GJCM, Buurman CJ, Staal A, Bos MP, Pols HAP 1992 Evidence for the functional involvement of protein kinase C in the action of 1,25-dihydroxyvitamin D3 in bone. J Biol Chem 267:112562-12569
65. Schneider HG, Michelangeli VP, Frampton RJ, Grogan JL, Ikeda K, Martin TJ, Findlay DM 1992 Transforming growth factor-β modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells. Endocrinology 131:1383-1389
66. Finkelman RD, Linkhart TA, Mohan S, Lau Kh Baylink DJ, Bell NH 1991 Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. Proc Natl Acad Sci USA 88:3657-3660
67. Petkovich PM, Wrana JL, Grigoriadis AE, Heersche JN, Sodek J 1987 1,25-dihydroxyvitamin D3 increases epidermal growth factor receptors and transforming growth factor beta-like activity in a bone-derived cell line. J Biol Chem 262:13424-13428